Survey of Antibiotic Resistance (SOAR) 218924: Antibacterial resistance among Streptococcus pneumoniae, and Haemophilus influenzae in Europe, Africa, Asia and the Middle East.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - Ongoing
Project Lead
Dr. Mary Dias, Dr. Anusha K R
Authors
Dr. Mary Dias, Dr. Anusha K R
Project Status
ongoing